Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Philippines Phamaceuticals and Healthcare Report Q1 2008

Published by: Business Monitor International

Published: Feb. 25, 2008 - 76 Pages


Table of Contents


Executive Summary
Philippines Pharmaceutical And Healthcare Industry SWOT
Philippines Political SWOT
Philippines Economic SWOT
Philippines Business Environment SWOT
The Philippines: Business Environment Ranking
Pharmaceutical Ratings - Revised Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Philippines - Pharmaceutical Business Environment Ranking
Table: Asia Pacific Pharmaceutical Business Environment Ratings
Limits Of Potential Returns
Risks To Realisation Of Returns
The Philippines - Market Summary
Regulatory Regime
Table: Timeline Of Cheaper Medicines Bill, 2007
Intellectual Property Regime
IP Shortcomings
IP Disputes
Counterfeit Drugs
Pricing And Reimbursement Regime
Parallel Trade
Corruption
International Co-operation
Industry Trends And Developments
Epidemiology
Healthcare Sector
Medical Tourism
Pharmaceutical Sector
Table Clinical Trial Considerations In Asia
Domestic Industry
Foreign Companies
Biotechnology
Traditional Medicines
Pharmaceutical Retail
Industry Forecast Sce34
Overall Market Forecast
Table: Philippines’ Pharmaceuticals Market Trends
Key Growth Factors - Industry
Table: Philippines’ Health Expenditure Forecasts
Key Growth Factors - Macroeconomic
Philippines Pharmaceuticals & Healthcare Report Q1 2008
Table: Philippines - Economic Activity
Prescription Market Forecast
Table: Philippines’ Prescription Drugs Market Indicators (US$mn unless otherwise stated)
OTC Market Forecast
Table: Philippines’ OTC Drugs Market Indicators (US$mn unless otherwise stated)
Generics And Patented Market Forecast
Table: Philippines’ Generics And Patented Market Forecasts
Export/Import Forecasts
Table: Philippines’ Pharmaceuticals Exports & Imports Forecasts (US$mn)
Other Healthcare Data Forecasts
Table: Philippines Other Health Indicators
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Table: Leading Firms And Medicines In the Philippines, Q405
Company Monitor
Leading Multinational Manufacturers
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi-Aventis
Abbott Laboratories
Bristol-Myers Squibb
Wyeth
Eli Lilly
Indigenous Manufacturers
Unilab
Pascual Laboratories
Pacific Pharmaceuticals
MediChem Pharmaceuticals
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources

Abstract

Until the ‘Cheaper Medicine Bill’ is fully approved by the legislature, we will be maintaining ourforecasts for the Philippines’ US$2.61bn pharmaceutical market. The new law is expected to reduce thecost of many medicines, but lowering our projections is not planned. In fact, given that more people onlow incomes will be able to afford quality healthcare products, we are more likely to upwardly revise ourexpectations for future sales. We are forecasting 5% year-on-year (y-o-y) growth through to 2012, whenthe market will have a valuation of US$4.02bn.

The Philippines has a nascent biotech sector, but there signs that expansion will occur soon. During Q407,local firm Servac Philippines has contracted Swedish company Pharmadule to build a state-of-the-artproduction facility. The US$120mn plant will make a vaccine for the prevention of rabies, which is asignificant problem in the country.

A prime indicator of the buoyant generic sector is The Generics Pharmacy, an enterprise that aimsexpand and extend the reach of generics to those on low incomes. Despite having only a minimalinvolvement with patented drugs, it is expanding rapidly. There are currently 27 outlets and the target isto have a 100 by mid-2008.

As part of its strategy to penetrate high growth markets, French firm Sanofi-Aventis' generics subsidiary- Winthrop Pharmaceuticals - opened a branch in Cebu Province, the Philippines. The firm aims toprovide high-quality and affordable medicines for a variety of conditions. To maximise sales, WinthropPharmaceuticals Philippines will liaise the government, presumably to get its products on state-assistedprogrammes.

According to a November 2007 poll, Filipinos are the second-happiest and most optimistic people inAsia, just behind the Indians, but ahead of the China, Thailand, Indonesia, Hong Kong, Malaysia andSingapore. This result is particularly surprising when one considers that the country has one of the lowestlevels of self-purchased and company-provided medical insurance.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008